Kadcyla, also referred to as T-DM1, is a targeted therapy for breast cancer treatment. In this video, oncologist Dr. Stephen Lemon describes how this FDA approved treatment works, as well as what types of side-effects it may cause.
Click on the buttons below to view more videos that we have produced
Facebook
Twitter
LinkedIn
Email